Literature DB >> 2163109

Molecular localization of the transforming and secretory properties of PDGF A and PDGF B.

W J LaRochelle1, N Giese, M May-Siroff, K C Robbins, S A Aaronson.   

Abstract

Human platelet-derived growth factor (PDGF) is a connective tissue cell mitogen comprised of two related chains encoded by distinct genes. The B chain is the homolog of the v-sis oncogene product. Properties that distinguish these ligands include greater transforming potency of the B chain and more efficient secretion of the A chain. By a strategy involving the generation of PDGF A and B chimeras, these properties were mapped to distinct domains of the respective molecules. Increased transforming efficiency segregated with the ability to activate both alpha and beta PDGF receptors. These findings genetically map PDGF B residues 105 to 144 as responsible for conformational alterations critical to beta PDGF receptor interaction and provide a mechanistic basis for the greater transforming potency of the PDGF B chain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163109     DOI: 10.1126/science.2163109

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor beta on endothelial cells.

Authors:  S W Qian; J K Burmester; J R Merwin; J A Madri; M B Sporn; A B Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 2.  Platelet-derived growth factor in human brain tumors.

Authors:  M Kirsch; J C Wilson; P Black
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 3.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. II. The platelet-derived growth factor A-chain contains a sequence that specifically binds heparin.

Authors:  G Fager; G Camejo; U Olsson; G Ostergren-Lundén; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

5.  A small v-sis/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity.

Authors:  N Giese; W J LaRochelle; M May-Siroff; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 6.  Signal transduction pathways and their relevance in human astrocytomas.

Authors:  M M Feldkamp; N Lau; A Guha
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

7.  High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.

Authors:  H G Cheon; W J LaRochelle; D P Bottaro; W H Burgess; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain.

Authors:  A Ostman; M Andersson; C Betsholtz; B Westermark; C H Heldin
Journal:  Cell Regul       Date:  1991-07

9.  Crystal structure of human platelet-derived growth factor BB.

Authors:  C Oefner; A D'Arcy; F K Winkler; B Eggimann; M Hosang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

10.  The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.

Authors:  D J Goldstein; T Andresson; J J Sparkowski; R Schlegel
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.